COSTA, A. L. L. et al. Correlação entre a classificação TNM, gradação histológica e
localização anatômica em carcinoma epidermóide oral. Pesq. Odontol. Bras., v. 16,
n. 3, p. 216-220, jul./set. 2002.
COSTA, A. L. L.; ARAÚJO JÚNIOR, R. F.; RAMOS, C. C. F. Correlação entre a
classificação clínica TNM e as características histológicas de malignidade do
carcinoma epidermóide oral. Rev. Bras. Otorrinolaringol., v. 71, n. 2, p. 181-7,
mar./abr. 2005.
COULTAS, L.; CHAWENGSAKSOPHAK, K.; ROSSANT, J. Endothelial cells and
VEGF in vascular development. Nature, v. 438, n. 7070, p. 937-45, Dec. 2005.
DANTAS, D.D.L. et al. Clinical-pathological parameters in squamous cell carcinoma
of the tongue. Braz. Dent. J., v. 14, n. 1, p. 22-25, June. 2003.
DEDIVITIS, R.A.; SEMENTILLI, A.; NISHIMOTO, I.N. Modo de invasão e sobrevida
no carcinoma espinocelular de língua oral. Rev. Bras. Cirur. Cabeça Pescoço, v.
30, n. 1, p. 7-10, jan./mar. 2003.
DERYNCK, R.; AKHURST, R.J.; BALMAIN, A. TGF-β signaling in tumor suppression
and cancer progression. Nat. Genet., v. 29, n. 2, p. 117-29, Oct. 2001.
DE BOSSCHER, K.; HILL, C.S.; NICOLAS, F.J. Molecular and functional
consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
Biochem J. v. 379, n. pt-1, p. 209–216, Apr. 2004.
DUFF, S. E., et al. CD105 is important for angiogenesis: evidence and potential
applications. FASEB J., v. 17, n. 9, p. 984-992, Jun. 2003.
FEELEY, B.T. et al. Overexpression of noggin inhibits BMP-mediated growth of
osteolytic prostate cancer lesions. Bone, v. 38, n. 2, p. 154-166, Feb. 2006.
FOLKMAN, J. Seminars in medicine of the Beth Israel hospital, Boston: Clinical
applications of research on angiogenesis. N. Engl. J. Med., v. 333, n. 26, p. 1757-
1763, Dec. 1995.
GARAVELLO, W. et al. Prognostic influence of gender in patients with oral tongue
cancer. Otolaryngol. Head Neck Surg., v.138, p. 768-771, 2008.
GAZZERRO, E.; GANGJI, V.; CANALIS, E. Bone Morphogenetic Protein induced the
expression of noggin, which limits their activity in cultured rat osteoblasts. J. Clin.
Invest., v. 102, n. 12, p. 2106-2114, Dec. 1998.
GAZZERRO, E.; CANALIS, E. Bone morphogenetic proteins and their antagonists.
Rev. Endocr. Metab. Disord., v.7, n. 1-2, p. 51-65, Jun. 2006.
GOSSELET, F.P. et al. BMP-2 and BMP-6 control p57
KIP2
expression and cell growth
arrest/terminal differentiation in normal primary human epidermal keratinocytes. Cell.
Signal, v. 19, n. 4, p. 731-739, Abr. 2007.